GGrantIndex
← Leaderboards

Christos J Petropoulos

Monogram Biosciences, Inc.

Google Scholar ↗PubMed ↗ORCID ↗
$13,434,107
Attributed
$13,434,107
Total exposure
13
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $3.1M · FY2005–15
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15

Funding mix

By agency

NIH$13,434,107 · 13

By mechanism

R44$8,351,317 · 4
R43$2,994,920 · 5
U19$1,279,707 · 1
R21$550,000 · 2
P01$258,163 · 1

Top collaborators

No co-investigators on record.

Most similar at Monogram Biosciences, Inc.

Same institution · by research overlap

Others in their field

Top investigators on “Drug Resistance”

Research focus

Drug ResistanceViralSamplingLaboratoriesClinical TrialsHiv-1PlasmaTechnologyVirusInfectionBaseCellsAnti-Retroviral AgentsPharmaceutical PreparationsPerformanceVirus ReplicationDesignHuman Immunodeficiency Virus 1EvaluationVariantTechnology /Technique DevelopmentHiv InfectionsGenesHiv Vaccine

Grant awards (29)

Quantitative Viral Outgrowth Assays with Improved Throughput and Performance$125,000
R21 · FY2015 · AI · contact PI
Assessing Potential Latent Virus HIV-1 Viability using Next Generation Sequencing$100,000
R21 · FY2015 · AI · contact PI
Assessing Potential Latent Virus HIV-1 Viability using Next Generation Sequencing$175,000
R21 · FY2014 · AI · contact PI
Quantitative Viral Outgrowth Assays with Improved Throughput and Performance$150,000
R21 · FY2014 · AI · contact PI
Novel Assays for Measuring Susceptibility to Inhibitors that Target HIV1 Virion A$299,156
R43 · FY2010 · AI · contact PI
HIV-1/SIV Antibody Neutralization Assay Improvements and Database Development$1,000,000
R44 · FY2009 · AI · contact PI
The Development of a Web-based Data Retrieval System for HIV Therapy Guidance$958,725
R44 · FY2009 · AI · contact PI
Novel Assays for Measuring Susceptibility to Inhibitors that Target HIV1 Virion A$299,636
R43 · FY2009 · AI · contact PI
HIV-1/SIV Antibody Neutralization Assay Improvements and Database Development$1,000,000
R44 · FY2008 · AI · contact PI
The Development of a Web-based Data Retrieval System for HIV Therapy Guidance$932,999
R44 · FY2008 · AI · contact PI
Novel Assays for measuring Integrase and RNase-H Inhibition$839,400
R44 · FY2008 · AI · contact PI
Tropism, Susceptibility and Resistance Deteminants$330,552
U19 · FY2008 · AI · contact PI
HIV-1/SIV Antibody Neutralization Assay Improvements and Database Development$1,000,000
R44 · FY2007 · AI · contact PI
Tropism, Susceptibility and Resistance Deteminants$413,157
U19 · FY2007 · AI · contact PI
Tropism, Susceptibility and Resistance Deteminants$418,737
U19 · FY2006 · AI · contact PI
Assay/Measuring HIV-1 and SIV Antibody Neutralization$298,628
R43 · FY2006 · AI · contact PI
NOVEL ASSAYS FOR MEASURING THE INHIBITION OF VIRUS ENTRY$776,731
R44 · FY2005 · AI
Assay/Measuring HIV-1 and SIV Antibody Neutralization$308,623
R43 · FY2005 · AI
Viral Neutralization Assays$258,163
P01 · FY2005 · AI
Tropism, Susceptibility and Resistance Deteminants$117,261
U19 · FY2005 · AI
NOVEL ASSAYS FOR MEASURING THE INHIBITION OF VIRUS ENTRY$841,731
R44 · FY2004 · AI
ASSAYS FOR MEASURING THE INHIBITION OF HIV-1 ENZYMES$300,000
R43 · FY2004 · AI
NOVEL ASSAYS FOR MEASURING THE INHIBITION OF VIRUS ENTRY$200,000
R44 · FY2004 · AI
NOVEL ASSAYS FOR MEASURING THE INHIBITION OF VIRUS ENTRY$801,731
R44 · FY2003 · AI
ASSAYS FOR MEASURING THE INHIBITION OF HIV-1 ENZYMES$299,563
R43 · FY2003 · AI
NOVEL ASSAY FOR MEASURING THE INHIBITION OF HIV-1 ENTRY$300,000
R43 · FY2002 · AI
A novel assay for measuring HIV-1 replication capacity$294,657
R43 · FY2002 · AI
NOVEL ASSAY FOR MEASURING THE INHIBITION OF HIV-1 ENTRY$300,000
R43 · FY2001 · AI
A novel assay for measuring HIV-1 replication capacity$294,657
R43 · FY2001 · AI